Tag: Pharma
USV sets up new plant at Vadodara
With an initial capital investment of around Rs 4000 million, the facility will provide employment to more than 350 people, despite being a very highly automated plant.........................
Roche appoints Omar Sherief Mohammad as new General Manager for India
Omar joins from Novo Nordisk, Vietnam where he was the General Manager, Southeast Asia - Emerging Markets...............
One year of Ayushman Bharat: MedTech & Pharma sectors expected to...
Within the healthcare industry, the medical devices segment is expected to be the biggest beneficiary, with additional revenues of USD 2 billion.................
‘Health Meets Hope’ at OPPI Health Dialogue 2019
The Health Dialogue 2019, curated by the Organisation of Pharmaceutical Producers of India witnessed the launch of #RefreshingResearch, a nation-wide digital campaign across pharma colleges. Research papers released at the event included.............
Sun Pharma makes an entry into generic pharma market in Mainland...
Sun Pharma and China Medical System Holdings have entered into licensing agreement for generic products in Mainland China..............
India’s biosimilars market stays buoyant
The entire gamut of biologic drugs, of which biosimilars are crucial, is set to become an integral part of the future healthcare landscape, writes Shveta Garg while taking us through the current status of the market and future perspectives...............
Nascent, but Indian genome sequencing market will take off soon
Experts suggest that it is a matter of time when products in genome sequencing will become affordable and the Indian genome sequencing market will progress towards maturity.................
Cipla USA furthers AMR stewardship with acquisition of key anti-infective ZEMDRI
Cipla USA to hold worldwide rights (excluding Greater China) of ZEMDRI™ (IV Plazomicin), an IV aminoglycoside with once-daily dosing for cUTI in adults, with proven activity against certain drug-resistant bacteria.......................
22 drugs in the market without approval, govt sends notices to...
The NPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs. 5.56 crore has been recovered and demand notices amounting to Rs. 89.31 crore are under litigation....................
Takeda expands India portfolio of rare disease therapies
The company has launched Enzyme Replacement Therapy bouquet for Lysosomal Storage Disorders (LSD), Idursulfase for Hunter Syndrome, Velaglucerase Alpha for Gaucher Disease and Agalsidase Alfa for Fabry Disease..........................